SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000914121-22-002824
Filing Date
2022-04-07
Accepted
2022-04-06 18:05:00
Documents
2
Group Members
CHRISTOPHER COXCLIVE MEANWELLPOPULATION HEALTH EQUITY PARTNERS III GP, LLCPOPULATION HEALTH EQUITY PARTNERS VII GP, LLCPOPULATION HEALTH EQUITY PARTNERS VII, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ph20220404-sc13d.htm SC 13D 127521
2 JOINT FILING AGREEMENT ph20220404-ex1.htm EX-1 15669
  Complete submission text file 0000914121-22-002824.txt   145082
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Subject) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92804 | Film No.: 22811627
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O POPULATION HEALTH EQUITY PARTNERS LP 1200 MORRIS TURNPIKE, SUITE 3005 SHORT HILLS NJ 07078
Business Address C/O POPULATION HEALTH EQUITY PARTNERS LP 1200 MORRIS TURNPIKE, SUITE 3005 SHORT HILLS NJ 07078 (212)-993-3113
Population Health Equity Partners III, L.P. (Filed by) CIK: 0001921616 (see all company filings)

IRS No.: 853693519 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D